@article{fc37432e62cc432086dbe390e06c939c,
title = "Letter: screening for infectious side effects in patients with IBD-the importance and potential of real-world remote monitoring",
author = "A.R. Ardabili and Z. Mujagic and D.M.A.E. Jonkers and M.J. Pierik",
note = "Funding Information: A. Rezazadeh Ardabili and Z. Mujagic have nothing to declare. D. Jonkers has received research funding from Top Knowledge Institute (Well on Wheat), Horizon 2020 DISCOvERIE, and NWO‐CCC Partnership program (Carbokinetics), all outside the submitted work. M.J. Pierik has served on advisory boards, as speaker or consultant for Abbvie, Janssen‐Cilag, MSD, Takeda, Ferring, Dr. Falk and Sandoz, and has received research funding from Janssen‐Cilag, Abbvie and Takeda, all outside the submitted work. Declaration of personal interests: Funding Information: This work was in part supported with an Investigator-Initiated research grant from Takeda (Grant number: 2019-102915). Declaration of personal interests: A. Rezazadeh Ardabili and Z. Mujagic have nothing to declare. D. Jonkers has received research funding from Top Knowledge Institute (Well on Wheat), Horizon 2020 DISCOvERIE, and NWO-CCC Partnership program (Carbokinetics), all outside the submitted work. M.J. Pierik has served on advisory boards, as speaker or consultant for Abbvie, Janssen-Cilag, MSD, Takeda, Ferring, Dr. Falk and Sandoz, and has received research funding from Janssen-Cilag, Abbvie and Takeda, all outside the submitted work. Declaration of funding interests: This study was in part funded with an investigator-initiated research grant by Takeda (2019-102915).",
year = "2022",
month = jan,
day = "1",
doi = "10.1111/apt.16707",
language = "English",
volume = "55",
pages = "260--261",
journal = "Alimentary Pharmacology & Therapeutics",
issn = "0269-2813",
publisher = "Wiley",
number = "2",
}